Tag: veterinary cro and cdmo market insights

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Veterinary CRO And CDMO Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

The veterinary CRO and CDMO sector has experienced substantial expansion over the past few years. It is projected to increase from $7.53 billion in 2025 to $8.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. This historical growth can be linked to factors such as veterinary firms’ constrained internal research and development capacities, an expanding companion animal population, an increase in animal disease occurrences, the prompt uptake of CDMO services in advanced economies, and the need for novel veterinary biologics and pharmaceuticals.

The veterinary CRO and CDMO market is projected to experience robust expansion over the coming years. It is anticipated to reach $11.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. This growth during the forecast period stems from factors such as a heightened demand for contract research and manufacturing services, advancements in veterinary drug development technology, the expansion of veterinary biologics and pharmaceuticals, a broadening of global regulatory compliance needs, and the increasing embrace of precision medicine for animals. Key trends expected during this period involve greater outsourcing of veterinary drug development, an increase in preclinical and clinical trial offerings, a rising need for regulatory consulting, the implementation of sophisticated analytical and formulation services, and an enhanced emphasis on post-marketing surveillance and pharmacovigilance.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=12080&type=smp&name=Veterinary%20CRO%20And%20CDMO%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary CRO And CDMO Market Demand Drivers: What’s Powering Industry Growth?

The future expansion of the veterinary CRO and CDMO market is anticipated to be fueled by an increase in pet ownership. Pet ownership refers to the status of an individual or household undertaking principal responsibility for a domesticated animal’s care, welfare, and management, which entails a lasting, lawful, and moral obligation. The rise in pet ownership is attributed to heightened understanding of the emotional and health advantages that pets offer, as individuals increasingly look for companionship, reduced stress, and better overall well-being through caring for pets. The veterinary CRO and CDMO market facilitates this growing pet ownership, with the expanding pet population stimulating the need for developing and producing veterinary drugs, vaccines, and therapies to guarantee the health and safety of animals. An example illustrates this: in March 2025, data from the American Pet Products Association, a US-based non-profit association, revealed that ninety-four (94) million U.S. households possess at least one pet, an increase from eighty-two (82) million in 2023. Consequently, the continued rise in pet ownership is projected to propel the veterinary CRO and CDMO market moving forward.

Veterinary CRO And CDMO Market Breakdown By Product Type And Application

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance

Veterinary CRO And CDMO Market Innovation Trends: What Developments Are Reshaping The Industry?

Leading enterprises within the veterinary CRO and CDMO market are concentrating on creating novel offerings, notably integrated multi-site CDMO networks. These networks incorporate sophisticated sterile manufacturing, lyophilization, and specific dosage capabilities, aiming to simplify drug development processes and expedite compliant routes to market. Integrated multi-site CDMO networks represent cohesive systems that bring together numerous production sites and specialized technologies, such as sterile multidose systems, lyophilization, and adaptable packaging, all managed under uniform operational and quality standards to provide comprehensive pharmaceutical development and manufacturing solutions. An illustration of this trend occurred in April 2025, when Meribel Pharma Solutions, a UK-based CDMO providing extensive services including drug development, formulation, analytical support, sterile and semi-solid manufacturing, and packaging, commenced operations. This involved a network of 13 facilities spread across France, Spain, and Sweden, designed to support products from initial development to commercial-scale production, with particular expertise in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health applications.

Veterinary CRO And CDMO Market Top Companies Driving Competitive Growth

Major companies operating in the veterinary cro and cdmo market are Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, Triveritas Ltd.

View The Full Veterinary CRO And CDMO Market Report:

https://thebusinessresearchcompany.com/report/veterinary-CRO-and-CDMO-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary CRO And CDMO Market Global Footprint: Which Region Leads The Market?

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Veterinary CRO And CDMO Market Revenue Outlook: What CAGR Lies Ahead Through 2030?#_x000D_

The veterinary CRO and CDMO sector has experienced substantial expansion over the past few years. It is projected to increase from $7.53 billion in 2025 to $8.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. This historical growth can be linked to factors such as veterinary firms’ constrained internal research and development capacities, an expanding companion animal population, an increase in animal disease occurrences, the prompt uptake of CDMO services in advanced economies, and the need for novel veterinary biologics and pharmaceuticals._x000D_

_x000D_

The veterinary CRO and CDMO market is projected to experience robust expansion over the coming years. It is anticipated to reach $11.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. This growth during the forecast period stems from factors such as a heightened demand for contract research and manufacturing services, advancements in veterinary drug development technology, the expansion of veterinary biologics and pharmaceuticals, a broadening of global regulatory compliance needs, and the increasing embrace of precision medicine for animals. Key trends expected during this period involve greater outsourcing of veterinary drug development, an increase in preclinical and clinical trial offerings, a rising need for regulatory consulting, the implementation of sophisticated analytical and formulation services, and an enhanced emphasis on post-marketing surveillance and pharmacovigilance._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=12080&type=smp&name=Veterinary%20CRO%20And%20CDMO%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary CRO And CDMO Market Demand Drivers: What’s Powering Industry Growth?#_x000D_

The future expansion of the veterinary CRO and CDMO market is anticipated to be fueled by an increase in pet ownership. Pet ownership refers to the status of an individual or household undertaking principal responsibility for a domesticated animal’s care, welfare, and management, which entails a lasting, lawful, and moral obligation. The rise in pet ownership is attributed to heightened understanding of the emotional and health advantages that pets offer, as individuals increasingly look for companionship, reduced stress, and better overall well-being through caring for pets. The veterinary CRO and CDMO market facilitates this growing pet ownership, with the expanding pet population stimulating the need for developing and producing veterinary drugs, vaccines, and therapies to guarantee the health and safety of animals. An example illustrates this: in March 2025, data from the American Pet Products Association, a US-based non-profit association, revealed that ninety-four (94) million U.S. households possess at least one pet, an increase from eighty-two (82) million in 2023. Consequently, the continued rise in pet ownership is projected to propel the veterinary CRO and CDMO market moving forward._x000D_

_x000D_

#Veterinary CRO And CDMO Market Breakdown By Product Type And Application#_x000D_

The veterinary cro and cdmo market covered in this report is segmented – _x000D_

_x000D_

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing_x000D_

2) By Animal Type: Companion Animals, Livestock Animals_x000D_

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization _x000D_

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting _x000D_

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services _x000D_

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance _x000D_

5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance _x000D_

_x000D_

#Veterinary CRO And CDMO Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_

Leading enterprises within the veterinary CRO and CDMO market are concentrating on creating novel offerings, notably integrated multi-site CDMO networks. These networks incorporate sophisticated sterile manufacturing, lyophilization, and specific dosage capabilities, aiming to simplify drug development processes and expedite compliant routes to market. Integrated multi-site CDMO networks represent cohesive systems that bring together numerous production sites and specialized technologies, such as sterile multidose systems, lyophilization, and adaptable packaging, all managed under uniform operational and quality standards to provide comprehensive pharmaceutical development and manufacturing solutions. An illustration of this trend occurred in April 2025, when Meribel Pharma Solutions, a UK-based CDMO providing extensive services including drug development, formulation, analytical support, sterile and semi-solid manufacturing, and packaging, commenced operations. This involved a network of 13 facilities spread across France, Spain, and Sweden, designed to support products from initial development to commercial-scale production, with particular expertise in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health applications._x000D_

_x000D_

#Veterinary CRO And CDMO Market Top Companies Driving Competitive Growth#_x000D_

Major companies operating in the veterinary cro and cdmo market are Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, Triveritas Ltd. _x000D_

_x000D_

#View The Full Veterinary CRO And CDMO Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/veterinary-CRO-and-CDMO-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary CRO And CDMO Market Global Footprint: Which Region Leads The Market?#_x000D_

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Veterinary CRO And CDMO Market Through 2030?

The veterinary cro and cdmo market has experienced substantial expansion in recent times. Forecasters predict this market will expand from $7.53 billion in 2025 to $8.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. The significant growth observed historically is primarily due to several factors, including the limited in-house R&D capabilities of veterinary companies, an expanding companion animal population, an increase in the prevalence of animal diseases, the early adoption of CDM/O services within developed regions, and a strong demand for innovative veterinary biologics and drugs.

The veterinary CRO and CDMO market is projected to experience substantial expansion over the coming years, reaching $11.81 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period is fueled by several factors, including a heightened demand for contract research and manufacturing services, innovations in veterinary drug development technology, the expansion of veterinary biologics and pharmaceuticals, an increase in global regulatory compliance mandates, and the growing use of precision medicine in animal care. Key trends expected during this period involve a rise in outsourcing for veterinary drug development, the broadening of preclinical and clinical trial offerings, an increasing need for regulatory consulting, the implementation of sophisticated analytical and formulation services, and an enhanced emphasis on post-marketing surveillance and pharmacovigilance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

What Market Drivers Are Helping Shape The Veterinary CRO And CDMO Market Expansion?

Increasing pet ownership is expected to propel the growth of the veterinary CRO and CDMO market going forward. Pet ownership is the state of being the primary person or household responsible for the care, well-being, and control of a domesticated animal. It involves a long-term, legal, and ethical commitment. Increasing pet ownership is rising due to the growing awareness of the emotional and health benefits of having pets, as people seek companionship, stress relief, and improved well-being through pet care. The veterinary CRO and CDMO market supports increasing pet ownership, as the growing number of pets drives demand for the development and manufacturing of veterinary drugs, vaccines, and treatments to ensure pet health and safety. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, ninety-four (94) million U.S. households own at least one pet, compared to eighty-two (82) million in 2023. Therefore, the increasing pet ownership is expected to drive the veterinary CRO and CDMO market going forward.

How Is The Veterinary CRO And CDMO Market Structured Across Different Market Segments?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance

What Trends Are Affecting The Veterinary CRO And CDMO Market Dynamics?

Major companies operating in the veterinary CRO and CDMO market are focusing on developing innovative services such as integrated multi-site CDMO networks with advanced sterile manufacturing, lyophilization, and specialized dosage capabilities to streamline drug development lifecycles and accelerate compliant commercialization pathways. Integrated multi-site CDMO networks are unified platforms that combine multiple manufacturing locations and specialized technologies including sterile multidose systems, lyophilization, and flexible packaging under harmonized operational and quality frameworks to deliver end-to-end pharmaceutical development and production services. For instance, in April 2025, Meribel Pharma Solutions, a UK-based full-service CDMO offering drug development, formulation, analytical services, sterile and semi-solid manufacturing, and packaging solutions, launched operations with a network of 13 facilities across France, Spain, and Sweden to support products from early development through commercial-scale production, providing centers of excellence in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health products.

Which Companies Form The Competitive Landscape Of The Veterinary CRO And CDMO Market?

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Veterinary CRO And CDMO Market Report:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Which Region Leads The Veterinary CRO And CDMO Market By Size?

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Veterinary CRO And CDMO Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Arthritis Monoclonal Antibodies Market At The End Of The 2026–2030 Forecast Period?

The veterinary cro and cdmo market size has experienced robust growth in recent years. Projections indicate a rise from $7.53 billion in 2025 to $8.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. Historically, this expansion has been driven by factors such as the restricted in-house research and development capacities of veterinary firms, an increasing population of companion animals, the growing incidence of animal diseases, the early integration of cdm/o services in advanced economies, and the demand for novel veterinary biologics and drugs.

The veterinary CRO and CDMO market is anticipated to show robust expansion over the next few years. It is projected to achieve a size of $11.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. The expansion during this forecast period is primarily driven by the escalating demand for contract research and manufacturing services, ongoing technological advancements in veterinary drug development, the growth of veterinary biologics and pharmaceuticals, an increase in global regulatory compliance requirements, and the rising adoption of precision medicine for animals. Significant trends expected in the forecast period encompass the increasing outsourcing of veterinary drug development, the expansion of preclinical and clinical trial services, a growing need for regulatory consulting services, the adoption of advanced analytical and formulation services, and a heightened focus on post-marketing surveillance and pharmacovigilance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

Which Market Drivers Are Supporting The Expansion Of The Arthritis Monoclonal Antibodies Market?

The veterinary CRO and CDMO market is anticipated to experience growth driven by increasing pet ownership in the coming years. Pet ownership signifies the role of an individual or household as the primary caregiver, responsible for the welfare and control of a domesticated animal, involving a lasting, legal, and moral obligation. This rise in pet ownership stems from a greater recognition of the emotional and health benefits pets provide, as people actively pursue companionship, relief from stress, and enhanced overall well-being through pet care. The veterinary CRO and CDMO market benefits from this trend, as the expanding number of pets generates demand for the creation and manufacturing of veterinary pharmaceuticals, vaccines, and treatments necessary for ensuring pet health and safety. Illustratively, in March 2025, the American Pet Products Association, a US-based non-profit association, reported that ninety-four (94) million U.S. households own at least one pet, an increase from eighty-two (82) million in 2023. Therefore, the ongoing rise in pet ownership is expected to stimulate the veterinary CRO and CDMO market moving forward.

What Segment Types Make Up The Arthritis Monoclonal Antibodies Market?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance

Which Market Trends Are Creating New Opportunities In The Veterinary CRO And CDMO Market?

Key entities active in the veterinary CRO and CDMO market are concentrating on developing novel services, including integrated multi-site CDMO networks equipped with advanced sterile manufacturing, lyophilization, and specialized dosage capabilities. This focus aims to simplify drug development processes and accelerate compliant commercialization. Integrated multi-site CDMO networks represent cohesive platforms that combine multiple manufacturing sites and specific technologies, such as sterile multidose systems, lyophilization, and flexible packaging, all governed by harmonized operational and quality frameworks to provide complete pharmaceutical development and production solutions. For example, in April 2025, Meribel Pharma Solutions, a UK-based full-service CDMO offering drug development, formulation, analytical services, sterile and semi-solid manufacturing, and packaging solutions, initiated its operations. This launch included a network of 13 facilities spread across France, Spain, and Sweden, intended to support products from early development through to commercial-scale production. The company provides specialized expertise in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health products.

Who Are The Key Players Driving Competition In The Arthritis Monoclonal Antibodies Market?

Major companies operating in the veterinary cro and cdmo market are Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, Triveritas Ltd.

Read the full veterinary cro and cdmo market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

How Is The Arthritis Monoclonal Antibodies Market Distributed Across Key Geographic Regions?

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Arthritis Monoclonal Antibodies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

Browse Through More Reports Similar to the Global Veterinary CRO And CDMO Market 2026, By The Business Research Company

Biologics Cdmo Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

Healthcare Cro Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Preclinical Cro Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Arthritis Monoclonal Antibodies Market At The End Of The 2026–2030 Forecast Period?

The veterinary cro and cdmo market size has experienced robust growth in recent years. Projections indicate a rise from $7.53 billion in 2025 to $8.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. Historically, this expansion has been driven by factors such as the restricted in-house research and development capacities of veterinary firms, an increasing population of companion animals, the growing incidence of animal diseases, the early integration of cdm/o services in advanced economies, and the demand for novel veterinary biologics and drugs.

The veterinary CRO and CDMO market is anticipated to show robust expansion over the next few years. It is projected to achieve a size of $11.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. The expansion during this forecast period is primarily driven by the escalating demand for contract research and manufacturing services, ongoing technological advancements in veterinary drug development, the growth of veterinary biologics and pharmaceuticals, an increase in global regulatory compliance requirements, and the rising adoption of precision medicine for animals. Significant trends expected in the forecast period encompass the increasing outsourcing of veterinary drug development, the expansion of preclinical and clinical trial services, a growing need for regulatory consulting services, the adoption of advanced analytical and formulation services, and a heightened focus on post-marketing surveillance and pharmacovigilance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

Which Market Drivers Are Supporting The Expansion Of The Arthritis Monoclonal Antibodies Market?

The veterinary CRO and CDMO market is anticipated to experience growth driven by increasing pet ownership in the coming years. Pet ownership signifies the role of an individual or household as the primary caregiver, responsible for the welfare and control of a domesticated animal, involving a lasting, legal, and moral obligation. This rise in pet ownership stems from a greater recognition of the emotional and health benefits pets provide, as people actively pursue companionship, relief from stress, and enhanced overall well-being through pet care. The veterinary CRO and CDMO market benefits from this trend, as the expanding number of pets generates demand for the creation and manufacturing of veterinary pharmaceuticals, vaccines, and treatments necessary for ensuring pet health and safety. Illustratively, in March 2025, the American Pet Products Association, a US-based non-profit association, reported that ninety-four (94) million U.S. households own at least one pet, an increase from eighty-two (82) million in 2023. Therefore, the ongoing rise in pet ownership is expected to stimulate the veterinary CRO and CDMO market moving forward.

What Segment Types Make Up The Arthritis Monoclonal Antibodies Market?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance

Which Market Trends Are Creating New Opportunities In The Veterinary CRO And CDMO Market?

Key entities active in the veterinary CRO and CDMO market are concentrating on developing novel services, including integrated multi-site CDMO networks equipped with advanced sterile manufacturing, lyophilization, and specialized dosage capabilities. This focus aims to simplify drug development processes and accelerate compliant commercialization. Integrated multi-site CDMO networks represent cohesive platforms that combine multiple manufacturing sites and specific technologies, such as sterile multidose systems, lyophilization, and flexible packaging, all governed by harmonized operational and quality frameworks to provide complete pharmaceutical development and production solutions. For example, in April 2025, Meribel Pharma Solutions, a UK-based full-service CDMO offering drug development, formulation, analytical services, sterile and semi-solid manufacturing, and packaging solutions, initiated its operations. This launch included a network of 13 facilities spread across France, Spain, and Sweden, intended to support products from early development through to commercial-scale production. The company provides specialized expertise in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health products.

Who Are The Key Players Driving Competition In The Arthritis Monoclonal Antibodies Market?

Major companies operating in the veterinary cro and cdmo market are Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, Triveritas Ltd.

Read the full veterinary cro and cdmo market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

How Is The Arthritis Monoclonal Antibodies Market Distributed Across Key Geographic Regions?

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Arthritis Monoclonal Antibodies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

Browse Through More Reports Similar to the Global Veterinary CRO And CDMO Market 2026, By The Business Research Company

Biologics Cdmo Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

Healthcare Cro Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Preclinical Cro Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the heat stress prevention products market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Veterinary CRO And CDMO Market?

The veterinary cro and cdmo market has experienced significant expansion in recent years. It is projected to expand from $7.53 billion in 2025 to $8.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. The market’s historical growth can be attributed to several factors, including the constrained in-house R&D capabilities of veterinary companies, an increasing companion animal population, a rise in the prevalence of animal diseases, the early adoption of CDM/O services within developed regions, and the demand for innovative veterinary biologics and drugs.

The veterinary CRO and CDMO market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $11.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. Key factors driving this growth during the forecast period include a rising demand for contract research and manufacturing services, progress in veterinary drug development technology, the expansion of veterinary biologics and pharmaceuticals, an increase in global regulatory compliance mandates, and the growing application of precision medicine in animal care. Significant trends expected in the forecast period encompass an uptick in the outsourcing of veterinary drug development, the broadening of preclinical and clinical trial offerings, an increasing need for regulatory consulting, the implementation of sophisticated analytical and formulation services, and a heightened emphasis on post-marketing surveillance and pharmacovigilance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

Which Drivers Are Supporting The Rise Of The Veterinary CRO And CDMO Market?

The projected increase in pet ownership is anticipated to fuel the expansion of the veterinary CRO and CDMO market. Pet ownership refers to the status of a person or household primarily responsible for the welfare, care, and management of a domesticated animal, embodying a lasting legal and ethical dedication. This rise in pet ownership stems from a growing understanding of the emotional and health advantages pets offer, as individuals increasingly seek companionship, stress reduction, and overall improved well-being through caring for animals. The veterinary CRO and CDMO market plays a crucial role in supporting this trend, as the growing population of pets necessitates increased demand for the creation and production of veterinary pharmaceuticals, vaccines, and therapies to safeguard pet health and safety. For instance, data from the American Pet Products Association, a US-based non-profit organization, indicates that by March 2025, ninety-four (94) million U.S. households will own at least one pet, an increase from eighty-two (82) million in 2023. Consequently, the surge in pet ownership is expected to propel the veterinary CRO and CDMO market forward.

What Segments Are Identified Within The Structure Of The Veterinary CRO And CDMO Market?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance

What Trends Are Projected To Support The Growth Of The Veterinary CRO And CDMO Market?

Key players within the veterinary CRO and CDMO market are concentrating on developing innovative services, such as integrated multi-site CDMO networks that incorporate advanced sterile manufacturing, lyophilization, and specialized dosage capabilities. This strategic focus aims to streamline drug development processes and accelerate compliant routes to commercialization. Integrated multi-site CDMO networks are unified platforms combining multiple production locations and expert technologies, including sterile multidose systems, lyophilization, and flexible packaging, all managed under harmonized operational and quality frameworks to deliver comprehensive pharmaceutical development and manufacturing services. For instance, in April 2025, Meribel Pharma Solutions, a UK-based full-service CDMO offering drug development, formulation, analytical services, sterile and semi-solid manufacturing, and packaging solutions, launched its operations. This launch included a network of 13 facilities across France, Spain, and Sweden, designed to support products from early development stages through to commercial-scale production, establishing centers of excellence in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health products.

Which Key Players Are Driving Competition In The Veterinary CRO And CDMO Market?

Major companies operating in the veterinary cro and cdmo market are Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, Triveritas Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Which Region Is Projected To Lead The Veterinary CRO And CDMO Market During The Forecast Period?

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary CRO And CDMO Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

Browse Through More Reports Similar to the Global Veterinary CRO And CDMO Market 2026, By The Business Research Company

Biologics Cdmo Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

Healthcare Cro Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Preclinical Cro Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary cro and cdmo market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Veterinary CRO And CDMO Market By The End Of 2029?

The market encompassing veterinary contract research organizations (CRO) and contract development and manufacturing organizations (CDMO) has seen robust expansion lately, projected to increase from its 6.97 billion U.S. dollars valuation in 2024 to reach 7.53 billion U.S. dollars by 2025, exhibiting a compound annual growth rate of 8.0%; this upward trajectory during the historical span is linked to factors such as escalating demands for adherence to regulations, the worldwide expansion of the animal health sector, greater investment in pharmaceutical creation for agricultural animals, and a rise in outsourcing activities undertaken by pharmaceutical corporations.

Anticipation surrounds the veterinary contract research organization and contract development and manufacturing organization sector, projecting considerable expansion across the forthcoming years; this market is slated to reach a valuation of $10.71 billion by the year 2029, reflecting a steady compound annual growth rate (CAGR) measured at 9.2%. This upward trajectory throughout the projected timeframe stems from several propelling factors, such as the escalating utilization of personalized medicine approaches, a heightened concentration on proactive health maintenance strategies, enhanced disease outbreak monitoring systems, greater readiness for urgent situations, and the growing intricacy associated with developing animal treatments. Key developments shaping this period involve the increasing tendency to contract out research and development activities, the blending of advanced technology into operations, the formation of strategic alliances and cooperative agreements, a growing commitment to environmentally conscious production methods, and the ongoing incorporation of digital tools across veterinary service delivery.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

Which Business Drivers Are Underpinning The Growth Of The Veterinary CRO And CDMO Market?

The trajectory of the veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market is anticipated to accelerate, largely fueled by escalating capital allocation toward animal healthcare. This surge in financial commitment to animal well-being stems from heightened recognition of its significance and a corresponding rise in the need for both veterinary services and related commodities, which in turn bolsters the veterinary CRO and CDMO sectors. To illustrate this trend, data released in October 2023 by the American Pet Products Association (APPA), a US-based entity dedicated to fostering pet ownership and the pet product sector, revealed that spending on pet care within the United States climbed from $123.6 billion in 2021 to $136.8 billion the following year; consequently, greater investment in animal healthcare is set to be the catalyst for expansion within the veterinary CRO and CDMO market.

What Are The Principal Segment Types In The Veterinary CRO And CDMO Market?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

How Are Industry Trends Steering The Expansion Of The Veterinary CRO And CDMO Market?

A significant trend emerging within the veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) sectors involves a pronounced emphasis on pioneering new products, as firms in these spheres actively channel efforts into product development to secure and maintain their competitive standing; for example, in June 2022, Vetio, an American CDMO concentrating solely on animal health, secured promising decisions from regulatory bodies, receiving an Intention to Grant from the European Patent Office (EPO) and a Notice of Allowance from the United States Patent Office (USPTO) regarding its proprietary Starch-Free Soft Chew formulation intended for animal medical uses. This specialized Soft Chew Technology platform, precisely engineered for animal health requirements by Vetio, excels at incorporating one or more therapeutic agents into a superior dosage form appropriate for veterinary pharmaceuticals, notably featuring a manufacturing method and composition entirely devoid of both starch and extraneous water, thereby offering outstanding compatibility for actives susceptible to degradation from moisture.

Which Companies Are Contributing Significantly To The Veterinary CRO And CDMO Market Growth?

Major companies operating in the veterinary cro and cdmo market include Eurofins Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc., Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Which Region Offers The Most Opportunity For Veterinary CRO And CDMO Market Expansion?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

Browse Through More Reports Similar to the Global Veterinary CRO And CDMO Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model